Clinical Trial Update: Tumor Microenvironment

View source ↗

Summary

Clinical trial update from University Hospital Heidelberg for lung adenocarcinoma, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Lung Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING